Exchange proteins directly activated by cAMP (EPACs)

Emerging therapeutic targets

Pingyuan Wang, Zhiqing Liu, Haiying Chen, Na Ye, Xiaodong Cheng, Jia Zhou

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Exchange proteins directly activated by cAMP (EPACs) are critical cAMP-dependent signaling pathway mediators. The discovery of EPAC proteins has significantly facilitated understanding on cAMP-dependent signaling pathway and efforts along this line open new avenues for developing novel therapeutics for cancer, diabetes, heart failure, inflammation, infections, neurological disorders and other human diseases. Over the past decade, important progress has been made in the identification of EPAC agonists, antagonists and their biological and pharmacological applications. In this review, we briefly summarize recently reported novel functions of EPACs and the discovery of their small molecule modulators. The challenges and future perspectives are also discussed.

Original languageEnglish (US)
Pages (from-to)1633-1639
Number of pages7
JournalBioorganic and Medicinal Chemistry Letters
Volume27
Issue number8
DOIs
StatePublished - Apr 15 2017

Fingerprint

Proteins
Therapeutics
Medical problems
Nervous System Diseases
Modulators
Heart Failure
Pharmacology
Inflammation
Molecules
Infection
Neoplasms

Keywords

  • Agonist
  • Antagonist
  • cAMP
  • EPAC
  • Modulator

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Exchange proteins directly activated by cAMP (EPACs) : Emerging therapeutic targets. / Wang, Pingyuan; Liu, Zhiqing; Chen, Haiying; Ye, Na; Cheng, Xiaodong; Zhou, Jia.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 27, No. 8, 15.04.2017, p. 1633-1639.

Research output: Contribution to journalReview article

Wang, Pingyuan ; Liu, Zhiqing ; Chen, Haiying ; Ye, Na ; Cheng, Xiaodong ; Zhou, Jia. / Exchange proteins directly activated by cAMP (EPACs) : Emerging therapeutic targets. In: Bioorganic and Medicinal Chemistry Letters. 2017 ; Vol. 27, No. 8. pp. 1633-1639.
@article{13f9993ef4ed4f27b60f04fe6bb98825,
title = "Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets",
abstract = "Exchange proteins directly activated by cAMP (EPACs) are critical cAMP-dependent signaling pathway mediators. The discovery of EPAC proteins has significantly facilitated understanding on cAMP-dependent signaling pathway and efforts along this line open new avenues for developing novel therapeutics for cancer, diabetes, heart failure, inflammation, infections, neurological disorders and other human diseases. Over the past decade, important progress has been made in the identification of EPAC agonists, antagonists and their biological and pharmacological applications. In this review, we briefly summarize recently reported novel functions of EPACs and the discovery of their small molecule modulators. The challenges and future perspectives are also discussed.",
keywords = "Agonist, Antagonist, cAMP, EPAC, Modulator",
author = "Pingyuan Wang and Zhiqing Liu and Haiying Chen and Na Ye and Xiaodong Cheng and Jia Zhou",
year = "2017",
month = "4",
day = "15",
doi = "10.1016/j.bmcl.2017.02.065",
language = "English (US)",
volume = "27",
pages = "1633--1639",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Exchange proteins directly activated by cAMP (EPACs)

T2 - Emerging therapeutic targets

AU - Wang, Pingyuan

AU - Liu, Zhiqing

AU - Chen, Haiying

AU - Ye, Na

AU - Cheng, Xiaodong

AU - Zhou, Jia

PY - 2017/4/15

Y1 - 2017/4/15

N2 - Exchange proteins directly activated by cAMP (EPACs) are critical cAMP-dependent signaling pathway mediators. The discovery of EPAC proteins has significantly facilitated understanding on cAMP-dependent signaling pathway and efforts along this line open new avenues for developing novel therapeutics for cancer, diabetes, heart failure, inflammation, infections, neurological disorders and other human diseases. Over the past decade, important progress has been made in the identification of EPAC agonists, antagonists and their biological and pharmacological applications. In this review, we briefly summarize recently reported novel functions of EPACs and the discovery of their small molecule modulators. The challenges and future perspectives are also discussed.

AB - Exchange proteins directly activated by cAMP (EPACs) are critical cAMP-dependent signaling pathway mediators. The discovery of EPAC proteins has significantly facilitated understanding on cAMP-dependent signaling pathway and efforts along this line open new avenues for developing novel therapeutics for cancer, diabetes, heart failure, inflammation, infections, neurological disorders and other human diseases. Over the past decade, important progress has been made in the identification of EPAC agonists, antagonists and their biological and pharmacological applications. In this review, we briefly summarize recently reported novel functions of EPACs and the discovery of their small molecule modulators. The challenges and future perspectives are also discussed.

KW - Agonist

KW - Antagonist

KW - cAMP

KW - EPAC

KW - Modulator

UR - http://www.scopus.com/inward/record.url?scp=85014660873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014660873&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2017.02.065

DO - 10.1016/j.bmcl.2017.02.065

M3 - Review article

VL - 27

SP - 1633

EP - 1639

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 8

ER -